Presentation Information

12:45 PM - 1:15 PM JST(3:45 AM - 4:15 AM UTC)

[L1-02]Development of LNP-mRNA vaccine against COVID-19

*Shoji Hirashima¹ (1. Representative Director, Head of JBU, Daiichi Sankyo Co., LTD. (Japan))

To browse or post comments, you must log in.Log in